Jump to:

Dolenio for osteoarthritis

27 May 2010, 10:13am

Dolenio for osteoarthritis

Dolenio is a new glucosamine product licensed for the symptomatic treatment of mild to moderate osteoarthritis of the knee.

Dolenio is a once daily tablet formulation of glucosamine sulphate.

Treatment may take several weeks or longer to provide relief of symptoms; if after 2 to 3 months no symptom relief is observed then continued treatment with glucosamine should be reviewed.

View Dolenio drug record

Further information: Blue Bio Pharmaceuticals

 

MIMS Specialist Journals

Now available on www.mims.co.uk

Click here to view

7-Part CME IBS Programme

Irritable bowel syndrome medical education programme worth 6.5 CPD credits. Click here to view

MIMS app

Access the full MIMS database from your mobile device

Click here to find out more

MIMs Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.

Find drugs by:

Travel Vaccination & Malaria Advice

Travel Vaccination & Malaria Advice

Supplied by the National
Travel Health Network
and Centre (NaTHNaC)

Palliative Care Resources

Palliative Care Resources

Opioid dose conversions
and much more

Childhood Immunisation

Childhood Immunisation

Summary of routine
vaccination schedule

Referral Guidelines for Breast Disorders

Referral Guidelines for Breast Disorders

MIMS Summary of NHS Cancer Screening Referral Guidelines

Quick-reference table: antibiotics

Quick-reference table: antibiotics

Treatment regimens for common infections

Back to top